Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Flores

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
American Journal of Physiology. Heart and Circulatory Physiology|May 12, 2009
Targeted disruption of the voltage-dependent calcium channel alpha2/delta-1-subunitGeraldine A Fuller-Bicer, Gyula Varadi, Sheryl E Koch, et al.
Journal of Medicinal Chemistry|April 9, 2015
Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep)William H Parsons, Raul R Calvo, Wing Cheung, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Protein Science : a Publication of the Protein Society|February 11, 2011
Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolutionCéline Schalk-Hihi, Carsten Schubert, Richard Alexander, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2019
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase InhibitorRyan M Wyatt, Ian Fraser, Natalie Welty, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 10, 2010
Diabetogenic effect of a series of tricyclic delta opioid agonists structurally related to cyproheptadineEllen E Codd, Judith Baker, Michael R Brandt, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
American Journal of Physiology. Heart and Circulatory Physiology|May 12, 2009
Targeted disruption of the voltage-dependent calcium channel alpha2/delta-1-subunitGeraldine A Fuller-Bicer, Gyula Varadi, Sheryl E Koch, et al.
Journal of Medicinal Chemistry|April 9, 2015
Benzo[d]imidazole Transient Receptor Potential Vanilloid 1 Antagonists for the Treatment of Pain: Discovery of trans-2-(2-{2-[2-(4-Trifluoromethyl-phenyl)-vinyl]-1H-benzimidazol-5-yl}-phenyl)-propan-2-ol (Mavatrep)William H Parsons, Raul R Calvo, Wing Cheung, et al.
Journal of Medicinal Chemistry|December 7, 2010
Design and optimization of benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonistsDaniel J Parks, William H Parsons, Raymond W Colburn, et al.
Protein Science : a Publication of the Protein Society|February 11, 2011
Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolutionCéline Schalk-Hihi, Carsten Schubert, Richard Alexander, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 11, 2019
Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase InhibitorRyan M Wyatt, Ian Fraser, Natalie Welty, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 10, 2010
Diabetogenic effect of a series of tricyclic delta opioid agonists structurally related to cyproheptadineEllen E Codd, Judith Baker, Michael R Brandt, et al.
Pageof 7